BEGIN:VCALENDAR
PRODID:-//Columba Systems Ltd//NONSGML CPNG/SpringViewer/ICal Output/3.3-
 M3//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20150331T105619Z
DTSTART:20150402T093000Z
DTEND:20150402T114500Z
SUMMARY:Syncona Partners Visit | Independent investment subsidiary of Wel
 lcome Trust
UID:{http://www.columbasystems.com/customers/uom/gpp/eventid/}v5g-i7x6vvw
 n-5c8i7w
DESCRIPTION:'''Host:''' \n\n\n'''About the event:''' \n\nUMIP are hosting
  an event with [http://www.synconapartners.com/ Syncona Partners] and we
  would like to invite you to attend.\n\nIraj Ali\, partner of Syncona Pa
 rtners\, is joining us to give a talk to an invited audience of academic
 s\, University business managers and UMIP about Syncona’s investment str
 ategy and interests. This will then be followed by a number of pre-booke
 d 30 minute 121 sessions with individuals who might have ideas to discus
 s.\n\n'''Areas of Interest:'''\n\nSyncona Partners are interested in Gen
 e and Cell Therapy\, including:\n\n*Engineered Cell Therapy\n**T-cell fo
 cus \n**Chimeric antigen receptor approaches \n**Extreme efficacy in end
 -stage cancer patients \n**Autologous product delivery infrastructure)\n
 \n*Patient Stratification \n**Patient selection to deliver extreme effic
 acy \n**Clinical genomics \n**Molecular Imaging\n\n*Gene Therapy \n**Len
 tiviral and AAV vector delivery \n**Severe monogenic disorders \n**Eye\,
  liver\, CNS opportunities \n**Pediatricinherited diseases\n\n*Targeted 
 Medicine is a theme common to all Target Areas \n**Extreme efficacy in t
 argeted patient groups \n**Health-economic outcomes and reimbursement dr
 iven by patient targeting\n\nThey are actively exploring new Health Care
  Investment Themes (“HIT”)\n\n'''Registration:''' \n\nPlease register fo
 r this event\, using [https://synconapartnersvisit.eventbrite.co.uk  Eve
 ntbrite]\n
STATUS:TENTATIVE
TRANSP:TRANSPARENT
CLASS:PUBLIC
LOCATION:Core Technology Facility\, Manchester
END:VEVENT
END:VCALENDAR